7,697.76

+128.84

+1.70%

53,288.37

+1,501.65

+2.90%

25,824.15

+452.14

+1.78%

2,856.43

+43.98

+1.56%

4.9060

-0.0460

-0.93%

17.00

-3.83

-18.40%

4,074.00

+133.60

+3.39%

80,305.15

+2,807.10

+3.62%

Crude Oil Dec 26

88.45

-7.64

-7.95%

US Private Equity

10,855.23

+18.94

+0.17%

NasdaqGS - Nasdaq Real Time Price USD

First Tracks Biotherapeutics, Inc. (TRAX)

48.41 +2.07 (+4.47%)

As of 1:45:55 PM EST. Market Open.

 All 
 News 
 Earnings Calls 
 Press Releases 
 SEC Filings 

First Tracks Biotherapeutics Announces Participation in Upcoming Investor Conferences

GlobeNewswire 21h ago

TRAX
+4.47%
First Tracks Biotherapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update

GlobeNewswire 21h ago

TRAX
+4.47%
First Tracks Biotherapeutics Announces $200 Million Private Placement

GlobeNewswire 20d ago

TRAX
+4.47%
7 Reasons First Tracks Biotherapeutics (TRAX) Looks Pricey Following ANB033 Trial Data

Simply Wall St. 22d ago

TRAX
+4.47%
First Tracks Biotherapeutics (TRAX) Stock Looks Rich Following Phase 1b Celiac Data

Simply Wall St. 22d ago

TRAX
+4.47%
First Tracks Biotherapeutics (TRAX) Reports Positive Phase 1b Cohort 1 Results

Simply Wall St. 22d ago

TRAX
+4.47%
First Tracks climbs on ‘impressive’ celiac study data

BioPharma Dive 22d ago

TRAX
+4.47%
Why This IPO Stock, An AnaptysBio Spinoff, Just Surged

Investor's Business Daily 22d ago

TRAX
+4.47%
ANAB
First Tracks’ ANB033 Clears Key Phase Ib Celiac Disease Study Goals

MarketBeat 23d ago

TRAX
+4.47%
First Tracks Biotherapeutics Shares Jump 20% After Positive Phase 1b Celiac Disease Trial Results

InvestorsHub 23d ago

TRAX
+4.47%
Why Is First Tracks Biotherapeutics Stock Soaring Monday?

Benzinga 23d ago

TRAX
+4.47%
First Tracks Biotherapeutics Announces Positive Top-Line Results for ANB033 in Gluten-Challenge Study in Celiac Disease

GlobeNewswire 23d ago

TRAX
+4.47%

Performance Overview

Return	TRAX	S&P 500 (^GSPC)
YTD	+139.80%	+12.61%
1-Year	+139.80%	+13.84%
3-Year	+139.80%	+76.87%

Mobilize your Website

View Site in Mobile | Classic

Share by: